Exhibit 23.1



Independent Registered Public Accounting Firm’s Consent


We consent to the inclusion in this Registration Statement of Relmada Therapeutics, Inc. on Form S-1 of our report dated September 28, 2018, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audit of the consolidated financial statements of Relmada Therapeutics, Inc. as of June 30, 2018 and for the year then ended, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.



/s/ Marcum llp


Marcum llp

Houston, Texas

August 12, 2019